Theratechnologies (TH) Reaches New 52-Week Low at $8.48
Theratechnologies Inc (TSE:TH) hit a new 52-week low during mid-day trading on Thursday . The company traded as low as C$8.48 and last traded at C$8.54, with a volume of 199671 shares. The stock had previously closed at C$8.62.
A number of brokerages have weighed in on TH. Canaccord Genuity lifted their target price on Theratechnologies from C$13.00 to C$14.50 in a research report on Friday, July 6th. National Bank Financial reaffirmed an “outperform” rating and set a C$14.25 target price on shares of Theratechnologies in a research report on Wednesday, June 20th. Finally, Royal Bank of Canada lifted their target price on Theratechnologies from C$11.00 to C$12.00 and gave the company a “sector perform” rating in a research report on Friday, October 5th.
Theratechnologies Company Profile (TSE:TH)
Theratechnologies Inc, a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. The company's lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada.
Recommended Story: What does the Dow Jones Industrial Average (DJIA) measure?
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.